首页 > 市场调查报告书 > 消费品

健康美容口腔衛生

市场调查报告书

商品编码

1741093

细菌性涎腺炎市场：按类型、按细菌类型、按腺体类型、按药物类别、按分销管道、按地区

Bacterial Sialadenitis Market, By Type, By Type of Bacteria, By Gland Type, By Drug Class, By Distribution Channel, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

简介目录

细菌性唾液腺炎市场规模预计在 2025 年达到 5.434 亿美元，预计到 2032 年将达到 7.697 亿美元，2025 年至 2032 年的复合年增长率为 5.1%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	5.434亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	5.10%	2032年价值预测	7.697亿美元

涎腺炎是指主要唾液腺（包括腮腺（位于双耳前方）、下颔下腺（位于口腔底部舌下）和舌下（位于口腔后部的舌下））的肿胀和增大。它可能是急性（突发性）、慢性（长期性）或復发性的。此病是由唾液腺导管感染或阻塞引起的。细菌性涎腺炎的常见病原体是金黄色葡萄球菌，但其他病原体也可能是病原体。细菌性涎腺炎通常伴随疼痛，并可能伴随发烧和寒颤。受累的唾液腺肿胀、发红、触痛，并且通常中央变色，这可能提示存在脓肿。

预防措施包括保持良好的口腔卫生、多喝水以及治疗可能增加细菌性唾液腺炎风险的潜在疾病。定期进行口腔护理并避免危险因子有助于降低患病风险。细菌性唾液腺炎的主要治疗方法是抗生素治疗，该疗法针对的是导致感染的特定细菌。此外，也建议补充水分、热敷和唾液腺按摩，以促进唾液分泌并缓解症状。在某些情况下，可能需要手术切除唾液腺结石或排放脓疡。

市场动态：

由于唾液腺感染疾病、唾液腺炎和修格兰氏症候群症等自体免疫疾病的盛行率不断上升，预计未来几年全球细菌性唾液腺炎市场将显着增长。

预计高昂的治疗费用和与感染相关的併发症将阻碍全球细菌性唾液腺炎市场的成长。

本研究的主要特点

本报告对全球细菌性唾液腺炎市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、业绩和策略等参数，介绍了主要企业的情况。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球细菌性涎腺炎市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过用于分析全球细菌性涎腺炎市场的各种策略矩阵来更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 543.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.10%	2032 Value Projection:	USD 769.7 Mn

Sialadenitis is swelling and enlargement of the major salivary glands, the parotid (in front of each ear), submandibular (under the tongue on the floor of the mouth) or sublingual (below the tongue in the back of the mouth). It can be acute (sudden) or chronic (long-term) or recurrent. The condition can be caused by infection or by a blockage of the gland's ducts. A common cause of bacterial sialadenitis is Staphylococcus aureus, but other organisms may also be responsible. Bacterial sialadenitis is usually painful and may be accompanied by fever and chills. The affected gland is swollen, red and tender and usually has a central area of discoloration, which may indicate an abscess.

Preventive measures include maintaining good oral hygiene, drinking enough water, and addressing underlying conditions that increase the risk of bacterial sialadenitis. Regular dental care and avoiding risk factors can help reduce the likelihood of developing the condition. The primary treatment for bacterial sialadenitis is antibiotic therapy to target the specific bacteria causing the infection. Adequate hydration, warm compresses, and gland massage may also be recommended to promote saliva flow and relieve symptoms. In some cases, surgical intervention may be necessary to remove salivary stones or drain abscesses.

Market Dynamics:

The global bacterial sialadenitis market is expected to witness significant growth in the coming years owing to rising incidence of conditions such as salivary gland infections, sialadenitis, and autoimmune diseases such as Sjogren's syndrome.

High cost of treatment and complications associated with the infection are expected to hinder growth of the global bacterial sialadenitis market over the forecast.

Key features of the study:

This report provides an in-depth analysis of the global bacterial sialadenitis market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bacterial sialadenitis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Johnson & Johnson, Abbott Laboratories, Eli Lilly and Company, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., and Allergan plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global bacterial sialadenitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacterial sialadenitis market

Detailed Segmentation:

By Type:
- Acute
- Chronic
Type of Bacteria:
- Staphylococcus aureus
- Streptococcus viridans
- Pseudomonas aeruginosa
- Escherichia coli
- Others (Haemophilus influenza, etc.)
By Gland Type:
- Parotid
- Submandibular
- Sublingual
By Drug Class
- Antibiotics
- Dicloxacillin
- Cephalosporin
- Clindamycin
- Analgesics
By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Ecommerce
By Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Company Profiles:
- Pfizer Inc.
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Novartis AG
- Sanofi S.A.
- Johnson & Johnson
- Abbott Laboratories
- Eli Lilly and Company
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- Roche Holding AG
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Allergan plc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Bacterial Sialadenitis Market, By Type
- Market Bacterial Sialadenitis Market, By Type of Bacteria
- Market Bacterial Sialadenitis Market, By Gland Type
- Market Bacterial Sialadenitis Market, By Drug Class
- Market Bacterial Sialadenitis Market, By Distribution Channel
- Market Bacterial Sialadenitis Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Bacterial Sialadenitis Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Bacterial Sialadenitis Market, By Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Acute
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Chronic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Bacterial Sialadenitis Market, By Type of Bacteria, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Staphylococcus aureus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Streptococcus viridans
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Pseudomonas aeruginosa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Escherichia coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Bacterial Sialadenitis Market, By Gland Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Paratoid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Submandibular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

8. Bacterial Sialadenitis Market, By Drug Class, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  - Dicloxacillin
  - Cephalosporin
  - Clindamycin
Analgesic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

9. Bacterial Sialadenitis Market, By Distribution Channel, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Ecommerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

10. Bacterial Sialadenitis Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Bacteria, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Gland Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
  - North Africa
  - South Africa
  - Central Africa

11. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

12. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

细菌性涎腺炎市场：按类型、按细菌类型、按腺体类型、按药物类别、按分销管道、按地区